FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$48.70 B | $59.28 B | $60.12 B | $64.17 B | $65.01 B | $65.59 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$13.63 B | $17.41 B | $16.13 B | $15.19 B | $12.03 B | $15.80 B |
Gross Profit Revenue minus cost of revenue. |
|
$35.08 B | $41.87 B | $43.99 B | $48.98 B | $52.98 B | $49.79 B |
|
Operating Expense
Costs to run business. 
|
|
$21.88 B | $23.59 B | $41.04 B | $28.75 B | $26.21 B | $31.69 B |
Operating Income Profit from operations. |
|
$13.20 B | $18.28 B | $2.95 B | $20.22 B | $26.78 B | $18.10 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$770.00 M | -$805.00 M | -$781.00 M | -$856.00 M | -$1.01 B | -$809.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$1.49 B | $876.00 M | -$81.00 M | -$986.00 M | $5.71 B | - |
Total Other Income (Net) Net non-operating items. |
|
$680.00 M | -$1.84 B | -$1.07 B | -$285.00 M | -$5.71 B | -$6.47 B |
Income Before Tax Profit before taxes. |
|
$13.88 B | $16.44 B | $1.89 B | $19.94 B | $21.07 B | $11.63 B |
Income Tax Expense Taxes on income. |
|
$1.52 B | $1.92 B | $1.51 B | $2.80 B | $2.80 B | $2.70 B |
|
Net Income
Final profit.
|
|
$13.05 B | $14.52 B | $365.00 M | $17.12 B | $18.25 B | $8.94 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$5.16 | $5.73 | $0.14 | $6.76 | $7.28 | $3.56 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$5.14 | $5.71 | $0.14 | $6.74 | $7.28 | $3.55 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
2.53 B | 2.53 B | 2.61 B | 2.53 B | 2.51 B | 2.47 B |
Diluted Average Shares Outst. Shares including dilution. |
|
2.54 B | 2.54 B | 2.55 B | 2.54 B | 2.51 B | 2.47 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$14.69 B | $17.41 B | $3.04 B | $21.21 B | $21.07 B | $18.10 B |
EBITDA Earnings before interest, tax, D&A. |
|
$17.90 B | $21.32 B | $6.91 B | $25.71 B | $25.36 B | $22.69 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$3.21 B | $3.91 B | $3.87 B | $4.50 B | $4.29 B | $4.59 B |
| Company Report |
FY 2025
Merck & Co.'s Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Merck & Co.'s Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Merck & Co.'s Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Merck & Co.'s Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
